INT197511

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.68
First Reported 2006
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 1.47
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (ABCA4) ATPase activity (ABCA4) plasma membrane (ABCA4)
transmembrane transport (ABCA4)
Anatomy Link Frequency
Fat 1
ABCA4 (Homo sapiens)
Pain Link Frequency Relevance Heat
cva 3 51.40 Quite High
tolerance 4 5.00 Very Low Very Low Very Low
addiction 2 5.00 Very Low Very Low Very Low
Inflammation 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
backache 2 5.00 Very Low Very Low Very Low
metalloproteinase 1 5.00 Very Low Very Low Very Low
Neuritis 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Eye Disease 21 97.80 Very High Very High Very High
Body Weight 6 93.08 High High
Infection 19 80.28 Quite High
Ganglion Cysts 2 77.12 Quite High
Syndrome 5 76.48 Quite High
Disease 35 75.56 Quite High
Retinal Dystrophies 2 69.64 Quite High
Glaucoma 2 66.32 Quite High
Cataract 2 65.76 Quite High
Retina Disease 5 65.36 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The benefit of finding a genetic association with specific genes is that we can begin to understand more about how the parasite triggers the development of ocular disease during embryogenesis and fetal development by examining what is known about the chronological expression and localization of COL2A1 and ABCA4 during development and after birth.
Localization (localization) of ABCA4 associated with eye disease
1) Confidence 0.68 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2390765 Disease Relevance 1.38 Pain Relevance 0.03
Fat mass (FM) and FFM were measured by DEXA on QDR 4500 W (Hologic, Massy, France) scanner using the QDR System Software for version 11.2.
Localization (measured) of FFM in Fat
2) Confidence 0.47 Published 2006 Journal PLoS Clinical Trials Section Body Doc Link PMC1584255 Disease Relevance 0.09 Pain Relevance 0
Expressed in mg/kg FFM and cumulative for both groups, postprandial glucose oxidation increased by 124 mg/kg FFM (95% CI, 28 to 220 mg/kg FFM; Wilcoxon sign-rank test p = 0.005) and lipid oxidation decreased by 36% (?
Localization (decreased) of FFM
3) Confidence 0.47 Published 2006 Journal PLoS Clinical Trials Section Body Doc Link PMC1584255 Disease Relevance 0 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox